Literature DB >> 22495343

Co-occurrence of different pathologies in dementia: implications for dementia diagnosis.

Carmen Echávarri1, Saartje Burgmans, Maria Cristina Caballero, Federico García-Bragado, Frans R J Verhey, Harry B M Uylings.   

Abstract

The standard for differentiating between dementia subtypes is currently based on neuropathological changes and follows traditional nosological classifications. However, the high incidence of comorbid neuropathologies complicates the differentiation between dementia diagnoses in the clinic. The aim of this study was to investigate the grades of agreement between clinical and neuropathological diagnoses in neurodegenerative disorders, to compare them with rates found in previous studies, and to propose implications for dementia diagnostics. Patients, who donated their brains to the Brain Bank of Navarre (Pamplona, Spain), had been diagnosed with a neurodegenerative disorder during life (clinical diagnosis) and postmortem (neuropathological diagnosis). We studied a sample of patients with a short average time interval between the last clinical assessment and death (4.6 months). Overall, there was a mean grade of agreement of 44.0% between the clinical diagnosis and the pure neuropathological diagnosis (i.e., without co-morbid neuropathological disorders). This grade of agreement differed between dementia subtypes: e.g., 85% for prion disease, 49% for Alzheimer's disease, and 0% for Lewy body dementia. Our data confirm that co-occurrence of multiple neuropathological disorders is very common in individuals with dementia, and that the underlying neuropathology often differs from the neuropathology implied by the clinical diagnosis. These findings support a multidimensional approach to diagnosing dementia, in which dementia syndromes are not categorized into diagnostic subtypes, but are seen as syndromes characterized by a combination of various neuropathological dimensions.

Entities:  

Mesh:

Year:  2012        PMID: 22495343     DOI: 10.3233/JAD-2012-111400

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  7 in total

Review 1.  Diabetes and cognition.

Authors:  Elizabeth Rose Mayeda; Rachel A Whitmer; Kristine Yaffe
Journal:  Clin Geriatr Med       Date:  2014-11-15       Impact factor: 3.076

2.  Aging alters mRNA expression of amyloid transporter genes at the blood-brain barrier.

Authors:  Doreen Osgood; Miles C Miller; Arthur A Messier; Liliana Gonzalez; Gerald D Silverberg
Journal:  Neurobiol Aging       Date:  2017-05-19       Impact factor: 4.673

Review 3.  Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy.

Authors:  Marie-Laure Caillet-Boudin; Francisco-Jose Fernandez-Gomez; Hélène Tran; Claire-Marie Dhaenens; Luc Buee; Nicolas Sergeant
Journal:  Front Mol Neurosci       Date:  2014-01-09       Impact factor: 5.639

4.  Stereotactic brain injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: A phase 1 clinical trial.

Authors:  Hee Jin Kim; Sang Won Seo; Jong Wook Chang; Jung Il Lee; Chi Hun Kim; Juhee Chin; Soo Jin Choi; Hunki Kwon; Hyuk Jin Yun; Jong Min Lee; Sung Tae Kim; Yearn Seong Choe; Kyung-Han Lee; Duk L Na
Journal:  Alzheimers Dement (N Y)       Date:  2015-07-26

5.  Comparison of clinical and neuropathological diagnoses of neurodegenerative diseases in two centres from the Brains for Dementia Research (BDR) cohort.

Authors:  Sashika Selvackadunco; Katie Langford; Zohra Shah; Siobhan Hurley; Istvan Bodi; Andrew King; Dag Aarsland; Claire Troakes; Safa Al-Sarraj
Journal:  J Neural Transm (Vienna)       Date:  2019-02-07       Impact factor: 3.575

6.  Cerebrospinal fluid α-synuclein predicts neurodegeneration and clinical progression in non-demented elders.

Authors:  Jie-Qiong Li; Yan-Lin Bi; Xue-Ning Shen; Hui-Fu Wang; Wei Xu; Chen-Chen Tan; Qiang Dong; Yan-Jiang Wang; Lan Tan; Jin-Tai Yu
Journal:  Transl Neurodegener       Date:  2020-11-23       Impact factor: 8.014

7.  Pathology and pathogenesis of vascular cognitive impairment-a critical update.

Authors:  Kurt A Jellinger
Journal:  Front Aging Neurosci       Date:  2013-04-10       Impact factor: 5.750

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.